Search

everythinglearnresearchcommunity

for

Search:↓

Some hormone treatments might raise breast cancer risk, while others don't seem to.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Chemotherapy is crucial for treating gynecological cancers but requires careful management due to severe side effects.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

No treatment fully prevents hair loss from chemotherapy yet.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

The conclusion is to diagnose PCOS with just hyperandrogenism and irregular periods, and treat with lifestyle changes and basic medications.

Women with PCOS may have a reduced ability to fight breast tumor cells over time.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Topical imiquimod use for treating a cervical lesion might cause delayed hair loss.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Metformin improves quality of life, emotional health, and sex life in women with polycystic ovary syndrome.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.